Soon after they were first described in 1990, aptamers were largely recognized as a new
class of biological ligands that can rival antibodies in various analytical, diagnostic, and …

Cancer is a group of disorders characterized by uncontrolled cell growth that affects around
11 million people each year globally. Nanocarrier-based systems are extensively used in …

Using nanoparticles to carry and delivery anticancer drugs holds much promise in cancer
therapy, but nanoparticles per se are lacking specificity. Active targeting, that is, using …

Development of multifunctional nanomaterials, one of the most interesting and advanced
research areas in the field of nanotechnology, is anticipated to revolutionize cancer …

Aptamers are single-stranded nucleic acid sequences that can bind to target molecules with
high selectivity and affinity. Most aptamers are screened in vitro by a combinatorial biology …

Although chemotherapy and photodynamic therapy (PDT) have been developed for fighting
cancer, the complex and heterogeneous nature of tumors makes it difficult for a single …

Aptamers are versatile nucleic acid-based macromolecules characterized by their high
affinity and specificity to a specific target. Taking advantage of such binding properties …

Today, RNA aptamers are being considered promising theranostic tools against a wide
variety of disorders. RNA aptamers can fold into complex shapes and bind to diverse …

Bacteria can infect the human body and cause disease, which endangers public safety. The
emergence of multidrug-resistant bacteria poses a great challenge on the treatment of …

Currently, precision theranostics have been extensively demanded for the effective
treatment of various human diseases. Currently, efficient therapy at the targeted disease …